Compound ID | 752
Class: Macrolide
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against clarithromycin-resistant Mycobacterium avium and Mycobacterium tuberculosis |
| Description: | A 9-oxime ether derivative of erythromycin |
| Institute where first reported: | Hokuriku Seiyaku (Abbvie, USA) |
| Year first mentioned: | 2001 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9575657 |
| Citation: | https://doi.org/10.1016/s1472-9792(08)70036-2 |